Clinical Trial Update: A Study to Evaluate the Intramuscular Administration of Scopolamine [Phase 1]

View source ↗

Summary

Phase 1 study evaluating intramuscular scopolamine as a medical countermeasure for organophosphate poisoning was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Organophosphate Poisoning

Drugs mentioned

• SCOPOLAMINE (SCOPOLAMINE)

Snippet

Sponsor: Battelle Memorial Institute | Conditions: Medical Countermeasures, Organophosphate Poisoning | Phase 1 | Status: TERMINATED | Results posted: 2025-02-19